Filling the need for trusted information on national health issues…

Generic Formulation Of Effective HIV Drug Becomes Available To Some Kenyans Through UNITAID Donation

Deutsche Welle: Kenya first in Africa to enroll new generic AIDS drug
“Kenya’s government and the global health initiative UNITAID announced Wednesday that the East African nation will make the generic version of dolutegravir [DTG] available for routine use…” (Muvunyi, 6/28).

Devex: Kenya becomes first country to debut generic HIV drug
“…DTG has been the preferred first-line treatment in the United States and Canada since 2014, a year after it came onto the market. Although some patients on the continent have accessed the more expensive version, the affordability of the generic DTG will be a ‘game changer’ in the treatment of HIV/AIDS, said Robert Matiru, UNITAID director of operations…” (Roby, 6/28).

Intellectual Property Watch: World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version
“…Medical experts said the drug — produced by Indian-based generic manufacturer Eurobindo Pharma Limited — has few side effects, is easier to take than other formulations (one small tablet taken daily) in use, and that those who use it are less likely to develop resistance…” (Nzwili, 6/29).

VOA News: Kenya’s New HIV Treatment Offers Hope for Patients
“…UNITAID donated approximately 148,000 bottles of DTG to Kenya’s Health Ministry, which will cover about one percent of the patients living with HIV in the country…” (Ruvaga, 6/28).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.